chr19-7689267-C-T
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001220500.2(FCER2):c.892G>A(p.Glu298Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00012 in 1,613,872 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001220500.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FCER2 | NM_001220500.2 | c.892G>A | p.Glu298Lys | missense_variant | 11/11 | ENST00000597921.6 | |
FCER2 | NM_002002.5 | c.892G>A | p.Glu298Lys | missense_variant | 11/11 | ||
FCER2 | NM_001207019.3 | c.889G>A | p.Glu297Lys | missense_variant | 10/10 | ||
FCER2 | XM_005272462.5 | c.892G>A | p.Glu298Lys | missense_variant | 11/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FCER2 | ENST00000597921.6 | c.892G>A | p.Glu298Lys | missense_variant | 11/11 | 1 | NM_001220500.2 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000683 AC: 104AN: 152182Hom.: 1 Cov.: 32
GnomAD3 exomes AF: 0.000173 AC: 43AN: 248188Hom.: 0 AF XY: 0.000112 AC XY: 15AN XY: 134518
GnomAD4 exome AF: 0.0000609 AC: 89AN: 1461572Hom.: 1 Cov.: 31 AF XY: 0.0000619 AC XY: 45AN XY: 727068
GnomAD4 genome AF: 0.000683 AC: 104AN: 152300Hom.: 1 Cov.: 32 AF XY: 0.000725 AC XY: 54AN XY: 74464
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 13, 2024 | The c.892G>A (p.E298K) alteration is located in exon 11 (coding exon 10) of the FCER2 gene. This alteration results from a G to A substitution at nucleotide position 892, causing the glutamic acid (E) at amino acid position 298 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at